Annual report pursuant to Section 13 and 15(d)

Net Loss Per Share (Details) - Schedule of diluted net loss per share

v3.22.1
Net Loss Per Share (Details) - Schedule of diluted net loss per share - shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 1,161,913 790,847
Stock options [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 118,388 118,388
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total common stock equivalents 1,043,525 672,459